Hyafil Fabien, Pelisek Jaroslav, Laitinen Iina, Schottelius Margret, Mohring Miriam, Döring Yvonne, van der Vorst Emiel P C, Kallmayer Michael, Steiger Katja, Poschenrieder Andreas, Notni Johannes, Fischer Johannes, Baumgartner Christine, Rischpler Christoph, Nekolla Stephan G, Weber Christian, Eckstein Hans-Henning, Wester Hans-Jürgen, Schwaiger Markus
Department of Nuclear Medicine, Klinikum Rechts der Isar, Munich, Germany
Department of Nuclear Medicine, Bichat University Hospital, Assistance Publique-Hôpitaux de Paris, Inserm 1148, DHU FIRE, University Diderot, Paris, France.
J Nucl Med. 2017 Mar;58(3):499-506. doi: 10.2967/jnumed.116.179663. Epub 2016 Oct 27.
Ga-pentixafor is a radiotracer for PET that binds with nanomolar affinity to CXCR4. The CXCR4 receptor is expressed at the surface of inflammatory cells. The objective of the study was to analyze the ability of radiolabeled pentixafor to detect CXCR4 expression on inflammatory cells present in atherosclerotic plaques of an experimental rabbit model. Atherosclerotic plaques were induced by endothelial abrasion of the right carotid artery and abdominal aorta of 7 rabbits fed an atherogenic diet. Five noninjured rabbits fed a chow diet were used as controls. Rabbits were imaged on a PET/MR system after injection of Ga-pentixafor (15 MBq/kg). Vascular signal was quantified as tissue-to-background ratio (TBR). Biodistribution and autoradiographic studies were performed 1 h after injection of I-pentixafor (7.5 MBq/kg). In addition, blocking studies were performed in 2 atherosclerotic rabbits with preinjection of the CXCR4 inhibitor AMD3100. Tracer uptake was quantified on arterial cryosections using autoradiography and compared with CXCR4 and RAM-11 (macrophage) expression on adjacent histologic sections. One hour after injection of Ga-pentixafor, strong signals were detected in vivo with PET/MR imaging in atherosclerotic plaques of the abdominal aorta and right carotid artery as compared with normal control arteries (mean TBR = 1.95 ± 0.51 vs. 1.22 ± 0.25 and mean TBR = 1.24 ± 0.38 vs. 0.96 ± 0.37, respectively; < 0.05 for both). Blocking studies with preinjection of a CXCR4 inhibitor reduced I-pentixafor uptake in atherosclerotic plaques by approximately 40%. I-pentixafor uptake in the vessel wall on autoradiographies was located in macrophage-rich regions of atherosclerotic plaques and correlated with the intensity of CXCR4 expression on corresponding cryosections ( = 0.61; < 0.05). Ga-pentixafor allows for the noninvasive detection of CXCR4 expression in the vessel wall with PET and emerges as a potential alternative to F-FDG for the assessment of macrophage infiltration in atherosclerotic plaques.
镓-喷替沙氟是一种用于正电子发射断层扫描(PET)的放射性示踪剂,它以纳摩尔亲和力与CXCR4结合。CXCR4受体在炎症细胞表面表达。本研究的目的是分析放射性标记的喷替沙氟检测实验性兔模型动脉粥样硬化斑块中炎症细胞上CXCR4表达的能力。通过对7只喂食致动脉粥样化饮食的兔子的右颈动脉和腹主动脉进行内皮损伤来诱导动脉粥样硬化斑块形成。5只喂食普通饮食的未受伤兔子作为对照。给兔子注射镓-喷替沙氟(15 MBq/kg)后,在PET/MR系统上进行成像。将血管信号量化为组织与本底比值(TBR)。在注射碘-喷替沙氟(7.5 MBq/kg)1小时后进行生物分布和放射自显影研究。此外,对2只动脉粥样硬化兔子在注射前预先注射CXCR4抑制剂AMD3100进行阻断研究。使用放射自显影对动脉冷冻切片上的示踪剂摄取进行量化,并与相邻组织学切片上的CXCR4和RAM-11(巨噬细胞)表达进行比较。注射镓-喷替沙氟1小时后,与正常对照动脉相比,在腹主动脉和右颈动脉的动脉粥样硬化斑块中通过PET/MR成像在体内检测到强信号(平均TBR分别为1.95±0.51对1.22±0.25以及平均TBR为1.24±0.38对0.96±0.37;两者均P<0.05)。预先注射CXCR4抑制剂的阻断研究使动脉粥样硬化斑块中碘-喷替沙氟的摄取减少了约40%。放射自显影中血管壁上碘-喷替沙氟的摄取位于动脉粥样硬化斑块富含巨噬细胞的区域,并与相应冷冻切片上CXCR4表达的强度相关(r = 0.61;P<0.05)。镓-喷替沙氟能够通过PET对血管壁中CXCR4表达进行无创检测,并成为用于评估动脉粥样硬化斑块中巨噬细胞浸润的F-FDG的潜在替代物。